Sort
64,565 grants matching “drug discovery”
EBV NUCLEAR PROTEINS IN B CELL GROWTH TRANSFORMATION
$870,000Brigham And Women'S Hospital · R01 · FY2005 · CA
Mechanisms of Chromosome Maintenance in Bacteria
$869,846Dhruba K Chattoraj · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Project 3: Defining and defeating the mechanisms of outer membrane biogenesis in Gram-negative bacteria
$869,512Thomas G Bernhardt · Harvard Medical School · U19 · FY2025 · AI
Novel Adjuvant Discovery in Vaccine Therapy
$869,286Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2011 · AI
Discovery and development of broad spectrum anti-flaviviral drugs
$869,118Mariano A. Garcia-Blanco · Duke University · R01 · FY2010 · AI
Bio-MicroElectroMechanical Systems Resource Center
$868,871Mehmet Toner · Massachusetts General Hospital · P41 · FY2006 · EB
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$868,716Nitin S Baliga · Institute For Systems Biology · R01 · FY2024 · AI
CTRIP: Treatment of Sickle Cell Crisis with inhibitors of NKT cell activation
$868,656David G. Nathan · Dana-Farber Cancer Inst · RC2 · FY2009 · HL
Structural features of the nuclear receptor signaling code
$868,500Kendall W Nettles · Scripps Florida · U01 · FY2013 · GM
Study on Thalidomide as BACE1 inhibitor in Alzhiemer's disease
$868,159Yong Shen · Banner Sun Health Research Institute · R01 · FY2009 · AG
Synthetic hydrogels for biomanufacturing of iPSC-derived neural cells for precision medicine
$868,100Connie S Lebakken · Stem Pharm, Inc. · R44 · FY2020 · NS
Biofluid Core
$868,029Adam L Boxer · Mayo Clinic Rochester · U19 · FY2021 · AG
Inexpensive Interactive Molecular Modeling Software
$867,851Verachem, Llc · R42 · FY2002 · GM
CANCER AND INFLAMMATION: FUNCTION AND THERAPY
$867,725Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Novel Technology for Reprocessing Flexible Endoscopes
$867,696Mohamed E Labib · Novaflux Technologies, Inc. · R44 · FY2007 · DK
Establishment and Characterization of Novel Mutant Mouse Models for the Addiction Research Community
$867,363Vivek Kumar · Jackson Laboratory · U01 · FY2024 · DA
ANTICANCER AGENTS FROM UNIQUE NATURAL PRODUCTS SOURCES
$867,251University Of Utah · U19 · FY2004 · CA
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal
$867,208Matthew G Dorsey · University Of California, San Francisco · U19 · FY2024 · AI
Therapeutic Development of Antimicrobial Biomimetics
$867,200Richard W Scott · Polymedix, Inc, · R44 · FY2008 · AI
The MetaCyc & BioCyc Pathway/Genome Databases (SRI Proposal ECU 14-630)
$867,121Peter D Karp · Sri International · R01 · FY2016 · GM
Countermeasures for Bioterroism Targeting Cellular Host Factors
$867,102John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2011 · AI
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms
$867,033Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
$866,894Tracy M Handel · University Of California, San Diego · U01 · FY2013 · GM
EOI::IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI MEDICATION DISCOVERY USING RAT MODELS OF RELAPSE. PERIOD OF PERFORMANCE: 7/10/
$866,812Virginia Commonwealth University · N01 · FY2025 · DA
An Ultrafast Electron Counting Camera for 100 kV Cryo-EM
$866,770Benjamin Eugene Bammes · Direct Electron, Lp · R44 · FY2021 · GM